AbCellera Biologics (ABCL) Construction in Progress (2023 - 2025)

AbCellera Biologics has reported Construction in Progress for 3 years, with the latest figure at $2.2 million in Q4 2025.

• For the quarter ending Q4 2025, Construction in Progress fell 84.72% year-over-year to $2.2 million; the trailing twelve-month figure through Dec 2025 stood at $2.2 million (down 84.72% YoY), and the FY2025 full-year result was $2.2 million, down 84.72% from the prior year.
• Construction in Progress for Q4 2025 stood at $2.2 million, down from $118.7 million in the prior quarter.
• The five-year high for Construction in Progress was $118.7 million in Q3 2025, with the low at $2.2 million in Q4 2025.
• Historically, Construction in Progress has averaged $23.4 million across 3 years, with a median of $14.4 million in 2024.
• The largest YoY upside for Construction in Progress was 670.78% in 2025 against a maximum downside of 84.72% in 2025.
• AbCellera Biologics' Construction in Progress stood at $13.7 million in 2023, then advanced by 5.11% to $14.4 million in 2024, then plunged by 84.72% to $2.2 million in 2025.
• The last three Construction in Progress figures came in at $2.2 million (Q4 2025), $118.7 million (Q3 2025), and $23.1 million (Q2 2025), per Business Quant data.